St. Jude's Starks' total compensation down in 2009

St. Jude Medical CEO Daniel Starks received $7.9 million in total compensation last year, down from $8.8 million in 2008, according to a filing with the SEC.

Starks' salary was $975,000, the same it was in 2007, but down from its 2008 level of $993,750, according to the filing. However, his annualized salary didn't actually change between 2007 and 2009, and the 2008 salary difference represents one additional week of payroll during that fiscal year.

In addition, Starks' stock-award compensation fell to $5.9 million in 2009, down from $6.4 million in the prior year, the Twin Cities Business Journal notes.

For 2010, Starks' base salary will be $995,000, according to the filing. Under Starks' leadership, St. Jude has grown from $2.3 billion in revenue in 2004, when Starks became the company's chairman, president and CEO, to $4.68 billion in 2009.  

- see the filing with the SEC
- check out the Twin Cities Business Journal's coverage

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.